Your Crystal Ball for 2016: Industry Trends to Watch

2016 pharma and biotech trends

Your Crystal Ball for 2016: Industry Trends to Watch

As a whole, healthcare is an ever-evolving industry, with new solutions and technologies being dreamed of and developed every day, around the globe. In the pharma and biotech space, we’re seeing significant movement in a variety of capacities. Many of these are considered game-changers, impacting everything from subject recruitment to medication shipment. Below, we’ve outlined a few of the areas where we’re seeing significant advances.

 

Medical Research and the Empowered Patient

“Until recently, public involvement in medical research has largely been restricted to participation in clinical studies. In 2016 we will see patient-centricity shift from a buzz word to meaningful actions that help sponsors involve and engage patients in clinical studies. Likewise, patient groups will be looking for better engagement and clearer information and there will be greater collaboration between the research industry, patient advocacy, and other non-profit patient organizations. Research design, protocol feasibility, and communication of study information and results will all be areas positively impacted by this paradigm shift.”

- Nancy Mulligan, Patient & Physician Recruitment

 

Pharmacogenomics is Moving Us toward Personalized Medicine

“Pharmacogenomics refers to the study of individuals’ genetic variations and how that impacts the way people respond to medications. We’re starting to see genotyping being used to determine if a specific regimen is appropriate for a particular disease. This means that we have the potential to tailor drug treatments to achieve optimal patient outcomes and minimize adverse reactions. This has incredible implications for the direction of healthcare in general – from the way we recruit for clinical trials to how we personalize therapy and adjust dosage.”

- Don A. Gabriel, MD, PhD, Medical Oncology & Scientific Strategy

 

Continued Research and Development of Wearable Technology

“Wearable technology hasn’t yet been widely tapped as a tool in clinical trials. However, the possibilities are vast. Industry leaders hope that current data and technology can be validated to use for common clinical trial assessments, and companies like Google are rumored to be working on wearable trackers that are built specifically for clinical use. Getting to this level will be groundbreaking and I am very excited to see what the future holds in the wearable space.”

- Mary James, Patient & Physician Services

 

Connected Healthcare, Streamlined Technology Solutions

“The face of reimbursement and patient access services is changing rapidly. Manual processes are being retired as we see new and stronger tools that support a more automated, streamlined workflow to assess a patient’s eligibility and drug coverage. Provider, payer, pharmacy, and claims routing system interoperability is allowing a more ‘connected’ system to address and streamline the patient referral process into reimbursement support programs. The maturation and utilization of e-prescribing tools is putting more information into the practitioner’s hands during the patient interaction, streamlining the ability to offer patient support and providing options for financial, clinical, or other support services. New tools are available to support and facilitate patient enrollment in Hub services, as well as support the burdensome process of gathering critical pieces of missing information that slows down the benefit and reimbursement process – ultimately, slowing patient speed to therapy.”

- Brett Huselton, Commercial Strategy & Opportunity Development

 

Contact us to learn more about what’s on the horizon for 2016. Here’s to a happy, healthy, and innovative new year!